Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipation Builds for CoDiagnostics Quarterly Earnings Report

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Stock Exchange
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Co-Diagnostics (NASDAQ: CODX) is gearing up to unveil its latest quarterly earnings report on March 14, 2024. Analysts are predicting an EPS of $-0.20 for this quarter.

In the previous quarter, Co-Diagnostics surprised everyone by surpassing EPS expectations by $0.09, causing a 10.24% decrease in the share price the next day.

As of March 12, the company’s stock was valued at $1.175, marking a 60.14% decline over the past year. Investors are eagerly awaiting not only a strong earnings performance but also optimistic guidance for future growth, as this can have a significant impact on stock prices.

CODX Stock Price Analysis: Slight Drop in Momentum on March 13, 2024

On March 13, 2024, CODX stock experienced a slight drop in its price momentum, trading in the middle of its 52-week range and below its 200-day simple moving average. The stock opened at $1.23, which was $0.05 higher than its previous close. Despite opening higher, the price of CODX shares decreased by $0.00 since the market last closed, resulting in a 0.36% drop. This slight decrease may have been influenced by various factors such as market conditions, investor sentiment, or company-specific news. Investors and analysts may be closely monitoring CODX stock performance to gauge its future trajectory. It will be interesting to see how the stock performs in the coming days and whether it can regain momentum to move towards its 200-day simple moving average. As always, it is important for investors to conduct thorough research and analysis before making any investment decisions. Stock prices can be volatile and unpredictable, so it is crucial to stay informed and make informed decisions based on reliable information.

CODX Stock Performance Analysis: Revenue Fluctuations and EPS Trends on March 13, 2024

On March 13, 2024, CODX stock experienced some interesting fluctuations in its financial performance. According to data from CNN Money, the company reported a total revenue of $34.22 million over the past year, which represents a significant decrease of 65.04% compared to the previous year. However, when looking at the quarterly revenue, CODX saw a substantial increase of 1142.18% since the last quarter, with total revenue reaching $2.46 million.

In terms of net income, CODX reported a loss of $14.24 million over the past year, indicating a decrease of 138.84% compared to the previous year. However, the company managed to reduce its losses in the last quarter, with a net loss of $5.98 million, representing an increase of 32.93% since the previous quarter.

Earnings per share (EPS) also showed mixed results for CODX stock. The company reported an EPS of -$0.45 over the past year, reflecting a decrease of 136.9% compared to the previous year. However, there was a positive trend in the last quarter, with an EPS of -$0.20, indicating an increase of 33.56% since the previous quarter.

Overall, the financial performance of CODX stock on March 13, 2024, showed a mix of positive and negative trends. Investors will be closely monitoring CODX stock to see if these trends continue in the future.

Tags: CODX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Stifel Analyst Reaffirms Buy Rating for Equinix with 960 Price Target

Bellevue dues

Analysts Remain Bullish on Alcon with Buy Ratings and Price Target Increases

why did walmart get rid of price scanners

Truist Securities Analyst Reaffirms Positive Outlook on Keros Therapeutics with 100 Price Target

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com